M, T., J, L., C, V., N, L., I, B., F, L., . . . F, F. (2021). DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist. PLoS pathogens, 17(5), e1009576. https://doi.org/10.1371/journal.ppat.1009576
Chicago Style (17th ed.) CitationM, Thépaut, et al. "DC/L-SIGN Recognition of Spike Glycoprotein Promotes SARS-CoV-2 Trans-infection and Can Be Inhibited by a Glycomimetic Antagonist." PLoS Pathogens 17, no. 5 (2021): e1009576. https://doi.org/10.1371/journal.ppat.1009576.
MLA (9th ed.) CitationM, Thépaut, et al. "DC/L-SIGN Recognition of Spike Glycoprotein Promotes SARS-CoV-2 Trans-infection and Can Be Inhibited by a Glycomimetic Antagonist." PLoS Pathogens, vol. 17, no. 5, 2021, p. e1009576, https://doi.org/10.1371/journal.ppat.1009576.